GRDX — GridAI Technologies Corp.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for GRDX in the TickerWise workspace.

GridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.

Company profile

• Sector: Healthcare
• Industry: Biotechnology
• Country: US
• Exchange: NASDAQ
• Employees: 2
• Website: https://www.grid-ai.com

Latest SEC filings for GRDX

• 2026-10-238-K
• 2026-10-20EFFECT
• 2026-10-06S-1/A
• 2026-08-24S-1/A
• 2026-07-31S-1/A
• 2026-07-238-K
• 2026-07-15D
• 2026-07-09S-1/A
• 2026-07-09S-1/A
• 2026-07-078-K/A

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.